Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 1.535
-0.110 (-6.69%)
Oct 27, 2026, 4:10 PM AEDT
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 300.97 million as of October 27, 2026. It is the 20,183rd most valuable company in the world and the 385th biggest in Australia. Its market cap has decreased by 50.61% in one year.
Market Cap
300.97M
Enterprise Value
266.68M
Revenue
2.81M
Global Rank
Country Rank
#385 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 300.97M, an increase of 2,281.59%. That is a compound annual growth rate of 36.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 300.97M | -39.03% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 592.27M |
| Clinuvel Pharmaceuticals | 361.57M |
| Tetratherix | 271.66M |
| Starpharma Holdings | 225.48M |
| BLS Pharmaceuticals | 222.24M |
| Actinogen Medical | 163.53M |
| Paradigm Biopharmaceuticals | 153.48M |
| Orthocell | 140.28M |